← feed

Is NCT02873156 results overdue?

Yes — results are overdue. Primary completion was 2017-11-29; the FDAAA-801 reporting deadline (2018-11-29) passed 2761 days ago and no results are posted on ClinicalTrials.gov.

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects

NCT IDNCT02873156 ↗
SponsorEisai Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-11-29 (ACTUAL)
Reporting deadline2018-11-29 (completion + 365d)
Days overdue2761
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 fa1cf94b12a64038… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02873156. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →